Polivy 140 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung - Swissmedic Key 67165002 Registration Holder Roche Pharma (Schweiz) AG Name Polivy 140 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung Date of registration 15.06.2021 Introduction of Sequence 15.06.2021 ATC-Classification (L01FX14) Revision date WHO WHO-DDD Valid until 14.06.2026 Index Therapeuticus (BSV) 07.16.10. Show package size Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 9215.41 Limitation Yes Limitation text
Deductible 10 % Consumer price 9762.80 Feedback FB GTIN 7680671650020 Medication Code Biotechnologika Pharmacode Disponibility
Composition polatuzumabum vedotinum 140 mg, acidum succinicum, natrii hydroxidum corresp. natrium 2.18 mg, saccharum, polysorbatum 20, pro vitro. Packungsbestandteile Galenic Form Excipiens BAG: Active Agent Dose 140 mg
Inactive agents Succinic Acid Sodium Hydroxide Saccharum
Source Data was imported : 14.04.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
